Scientists from leading academic institutions worldwide are invited to submit original project proposals to develop novel approaches to remove saliva derived, mixed-species, and potentially pathogenic bacterial biofilms.
BioMed X Innovation Center announced today that they have entered into a collaboration agreement with Johnson & Johnson Consumer seeking to establish a research group to focus on the development of novel methods for the disruption of oral biofilms. This collaboration was facilitated by Johnson & Johnson Innovation.
Through a joint crowdsourcing effort, scientists from leading academic institutions worldwide are invited to submit original project proposals to develop novel approaches to remove saliva derived, mixed-species, and potentially pathogenic bacterial biofilms from oral surfaces to reduce the incidence of gum disease or caries.
The best ideas and life science talents will be jointly selected to form a new research group within BioMed X’s open innovation lab, which is part of the vibrant life science campus of the University of Heidelberg.«We are excited about the collaboration since it extends our research project portfolio into the field of consumer health care,» said Christian Tidona, founder and Managing Director of BioMed X. «With Johnson & Johnson Innovation we welcome the fifth global player to join our new open innovation model.»
BioMed X will be responsible for housing the new research group, the operation of the innovation center facility and enabling access to the Heidelberg scientific community and research facilities.